Annual report pursuant to Section 13 and 15(d)

Note 3 - Supplemental Balance Sheet and Cash Flow Information - Changes in Carrying Amount of Goodwill (Details)

v3.7.0.1
Note 3 - Supplemental Balance Sheet and Cash Flow Information - Changes in Carrying Amount of Goodwill (Details) - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Balance $ 430,882 $ 390,638
Acquisitions (Note 2) 147,484 49,547
Prior year acquisitions (Note 2) 1,809
Currency translation (1,149) (9,303)
Balance 579,026 430,882
Biotechnology [Member]    
Balance 108,723 115,198
Acquisitions (Note 2) 147,484
Prior year acquisitions (Note 2)
Currency translation (1,277) (6,475)
Balance 254,930 108,723
Diagnostics [Member]    
Balance 103,270 60,601
Acquisitions (Note 2) 42,669
Prior year acquisitions (Note 2)
Currency translation
Balance 103,270 103,270
Protein Platforms [Member]    
Balance 218,889 214,839
Acquisitions (Note 2) 6,878
Prior year acquisitions (Note 2) 1,809
Currency translation 128 (2,828)
Balance $ 220,826 $ 218,889